Intravenous iron therapy for patients with heart failure: a meta-analysis stratified by chronic kidney disease status.
- 2026-03-27
- Meta-Analysis · n = 7,009
- BMC cardiovascular disorders 26(1)
- Yiran Du
- Yingnan Liang
- Jie Lv
- Zhen Wang
- Xiaowen Li
- Zhenjie Chen
- Jingwei Zhou
- PubMed: 41896739
- DOI: 10.1186/s12872-026-05672-5
- High evidence
- Clinical
IV iron therapy showed a significantly reduced incidence of first heart failure hospitalization or cardiovascular death (RR = 0.79, 95% CI: 0.72–0.86, P < 0.001)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes